Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC - StockTitan
| THCT Stock | USD 0.0006 0.0001 20.00% |
Slightly above 55% of THC Therapeutics' private investors are presently thinking to get in. The analysis of overall sentiment of trading THC Therapeutics pink sheet suggests that some investors are interested at this time. THC Therapeutics' investing sentiment can be driven by a variety of factors including economic data, THC Therapeutics' earnings reports, geopolitical events, and overall market trends.
THC |
Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC StockTitan
Read at news.google.com
 |
THC Therapeutics Fundamental Analysis
We analyze THC Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of THC Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of THC Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
THC Therapeutics is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
THC Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with THC Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of THC Therapeutics could also be used in its relative valuation, which is a method of valuing THC Therapeutics by comparing valuation metrics with similar companies.
Peers
THC Therapeutics Related Equities
| PEPG | PepGen | 18.22 | ||||
| MNOV | MediciNova | 14.98 | ||||
| HCWB | HCW Biologics | 8.51 | ||||
| PMVP | Pmv Pharmaceuticals | 4.32 | ||||
| RZLT | Rezolute | 1.19 | ||||
| AVTE | Aerovate Therapeutics | 1.14 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
| ADAG | Adagene | 6.41 | ||||
| MOLN | Molecular Partners | 7.22 | ||||
| PHVS | Pharvaris | 12.56 |
Additional Tools for THC Pink Sheet Analysis
When running THC Therapeutics' price analysis, check to measure THC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Therapeutics is operating at the current time. Most of THC Therapeutics' value examination focuses on studying past and present price action to predict the probability of THC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Therapeutics' price. Additionally, you may evaluate how the addition of THC Therapeutics to your portfolios can decrease your overall portfolio volatility.